Table 2.
Univariate and multivariate analyses of predictive risk factors for ER in resectable pancreatic cancer.
| Preoperative risk factors | Univariable | Multivariable | ||
|---|---|---|---|---|
| Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |
| Age:<61years versus ≥ 61 years | 0.730 (0.529–1.007) | .055 | ||
| Gender: female versus male | 1.205 (0.870–1.668) | .261 | ||
| Weight loss | 0.782 (0.556–1.080) | .136 | ||
| Clinical symptoms: yes or no | 0.515 (0.365–0.726) | .000 | 0.451 (0.310–0.654) | .000 |
| Diabetes: yes versus no | 1.123 (0.783–1.610) | .530 | ||
| Expansion of the pancreatic duct | 0.876 (0.630–1.218) | .431 | ||
| Charlson age-comorbidity index: | 0.628 (0.446–0.884) | .008 | 0.639 (0.440–0.929) | .019 |
| Tumor size | 0.628 (0.455–0.867) | .005 | 0.686 (0.485–0.970) | .033 |
| Tumor location | 0.930 (0.662–1.307) | .676 | ||
| Preop CA 19-9 | 0.396 (0.284–0.551) | .000 | 0.428 (0.304–0.602) | .000 |
| Preop CEA | 0.440 (0.296–0.653) | .000 | 0.644 (0.418–0.988) | .047 |
| Preop CA242 | 0.433 (0.308–0.608) | .000 | 0.689 (0.423–1.123) | .135 |
ER = early recurrence.